1. Home
  2. BNED vs STRO Comparison

BNED vs STRO Comparison

Compare BNED & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$13.58

Market Cap

467.3M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$9.36

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNED
STRO
Founded
1965
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
467.3M
181.4M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
BNED
STRO
Price
$13.58
$9.36
Analyst Decision
Buy
Strong Buy
Analyst Count
2
14
Target Price
$17.25
★ $47.23
AVG Volume (30 Days)
199.8K
★ 271.7K
Earning Date
09-08-2026
11-05-2026
Dividend Yield
★ 2.29%
N/A
EPS Growth
★ 119.60
N/A
EPS
★ N/A
N/A
Revenue
★ $1,714,770,000.00
$38,419,000.00
Revenue This Year
$3.88
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 6.50
N/A
52 Week Low
$5.90
$0.72
52 Week High
$14.75
$43.85

Technical Indicators

Market Signals
Indicator
BNED
STRO
Relative Strength Index (RSI) 67.02 22.90
Support Level $11.55 N/A
Resistance Level $14.75 $16.99
Average True Range (ATR) 0.43 1.23
MACD 0.18 -0.15
Stochastic Oscillator 83.33 2.70

Price Performance

Historical Comparison
BNED
STRO

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is contract operators of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also one of the textbook wholesalers and inventory management hardware and software providers The company operates physical and virtual bookstores that delivers essential educational content and general merchandise within a dynamic omnichannel retail environment. The Company currently operates as a single operating and reporting segment. The company's solutions are Academic Solutions, College Retail Solutions, College Insights, Wholesale & Store Technology Services.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: